Association of RASSF1A promoter methylation with gastric cancer risk: A meta-analysis

Tumor Biology

Volumn 35, Issue 2, 2014, Pages 943-948

  Shi, Dong Tao ^a   Han, Mei ^a   Gao, Nan ^a   Tian, Wenyan ^a   Chen, Weichang ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Gastric cancer; Methylation; RASSF1A; Risk; Tumor suppressor gene

Indexed keywords

RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ARTICLE; CANCER RISK; CANCER TISSUE; CHI SQUARE TEST; ETHNICITY; HUMAN; MATERIALS TESTING; META ANALYSIS; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; PUBLISHING; QUANTITATIVE ANALYSIS; STOMACH CANCER; SYSTEMATIC REVIEW;

DNA METHYLATION; ETHNIC GROUPS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PROGNOSIS; PROMOTER REGIONS, GENETIC; RISK FACTORS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 84899063661     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1123-2     Document Type: Article

References (38)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol. 2003;56:1-9. (Pubitemid 36183309)
3. Kikuchi S. Epidemiology of Helicobacter pylori and gastric cancer. Gastric Cancer. 2002;5:6-15. (Pubitemid 34496346)
4. Yokozaki H, Yasui W, Tahara E. Genetic and epigenetic changes in stomach cancer. Int Rev Cytol. 2001;204:49-95. (Pubitemid 32185170)
5. Tamura G. Genetic and epigenetic alterations of tumor suppressor and tumor-related genes in gastric cancer. Histol Histopathol. 2002;17:323-9. (Pubitemid 34116433)
6. Sapari NS, Loh M, Vaithilingam A, Soong R. Clinical potential of DNA methylation in gastric cancer: a meta-analysis. PLoS One. 2012;7:e36275.
7. Gigek CO, Chen ES, Calcagno DQ, Wisnieski F, Burbano RR, Smith MA. Epigenetic mechanisms in gastric cancer. Epigenomics. 2012;4:279-94.
8. Agathanggelou A, Cooper WN, Latif F. Role of the ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res. 2005;65:3497-508. (Pubitemid 40616319)
9. Pfeifer GP, Yoon JH, Liu L, Tommasi S, Wilczynski SP, Dammann R. Methylation of the rassf1a gene in human cancers. Biol Chem. 2002;383:907-14. (Pubitemid 34874094)
10. Dammann R, Schagdarsurengin U, Seidel C, Strunnikova M, Rastetter M, Baler K, et al. The tumor suppressor rassf1a in human carcinogenesis: an update. Histol Histopathol. 2005;20:645-63. (Pubitemid 40468282)
11. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a ras association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet. 2000;25:315-9. (Pubitemid 30437320)
12. Hesson LB, Cooper WN, Latif F. The role of rassf1a methylation in cancer. Dis Markers. 2007;23:73-87. (Pubitemid 46333640)
13. Byun DS, Lee MG, Chae KS, Ryu BG, Chi SG. Frequent epigenetic inactivation of rassf1a by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res. 2001;61:7034-8.
14. To KF, Leung WK, Lee TL, Yu J, Tong JH, Chan MW, et al. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer. 2002;102:623-8. (Pubitemid 35334471)
15. Balassiano K, Lima S, JenabM, Overvad K, Tjonneland A, Boutron-Ruault MC, et al. Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European prospective investigation into cancer and nutrition (epic-eurgast). Cancer Lett. 2011;311:85-95.
16. Dickersin K, Berlin JA. Meta-analysis: state-of-the-science. Epidemiol Rev. 1992;14:154-76. (Pubitemid 23024558)
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60. (Pubitemid 37088507)
18. Mantel N, HaenszelW. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
19. DerSimonian R, LairdN.Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88. (Pubitemid 17189972)
20. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test.BMJ. 1997;315:629-34. (Pubitemid 27387172)
21. Kang GH, Lee S, Kim JS, Jung HY. Profile of aberrant cpg island methylation along the multistep pathway of gastric carcinogenesis. Lab Investig. 2003;83:635-41. (Pubitemid 36618042)
22. Ye M, Xia B, Guo QS, Zhou F, Zhang XL. [The influence of promoter methylation of rassf1a on rassf1a mrna and protein expression in gastric cancer tissues]. Zhonghua Nei Ke Za Zhi. 2006;45:1008-12.
23. Kang GH, Lee S, Kim JS, Jung HY. Profile of aberrant cpg island methylation along multistep gastric carcinogenesis. Lab Investig. 2003;83:519-26. (Pubitemid 36457706)
24. Ye M, Xia B, Guo Q, Zhou F, Zhang X. Association of diminished expression of rassf1a with promoter methylation in primary gastric cancer from patients of central china. BMC Cancer. 2007;7:120.
25. Wang YC, Yu ZH, Liu C, Xu LZ, Yu W, Lu J, et al. Detection of rassf1a promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.World J Gastroenterol. 2008;14:3074-80.
26. Guo W, Dong ZM, Chen ZF, Yang ZB, Wen DG, Kuang G, et al. Aberrant cpg island hypermethylation of rassf1a in gastric cardia adenocarcinoma. Cancer Investig. 2009;27:459-65.
27. Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Hum Pathol. 2009;40:1534-42.
28. Yao D, Shi J, Shi B, Wang N, Liu W, Zhang G, et al. Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer. Clin Chim Acta. 2012;413:787-94.
29. Tan SH, Ida H, Lau QC, Goh BC, Chieng WS, Loh M, et al. Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including runx3. Oncol Rep. 2007;18:1225-30.
30. Zhou SL, Cui J, Fan ZM, Li XM, Li JL, Liu BC, et al. Polymorphism of A133S and promoter hypermethylation in Ras association domain family 1A gene (RASSF1A) is associatedwith risk of esophageal and gastric cardia cancers in Chinese population fromhigh incidence area in northern China. BMC Cancer. 2013;13:259.
31. Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol. 2005;2 Suppl 1:S4-S11. (Pubitemid 43135229)
32. Das PM, Singal R. DNA methylation and cancer. J Clin Oncol. 2004;22:4632-42. (Pubitemid 41185132)
33. Lau J, Ioannidis JP, Schmid CH. Summing up evidence: one answer is not always enough. Lancet. 1998;351:123-7. (Pubitemid 28026648)
34. Roder DM. The epidemiology of gastric cancer. Gastric Cancer. 2002;5 Suppl 1:5-11. (Pubitemid 36604663)
35. Wang J, Wang B, Chen X, Bi J. The prognostic value of rassf1a promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis. Carcinogenesis. 2011;32:411-6.
36. Gao T, Wang S, He B, Pan Y, Song G, Gu L, et al. The association of ras association domain family protein1a (rassf1a) methylation states and bladder cancer risk: a systematic review andmeta-analysis. PLoS One. 2012;7:e48300.
37. Jiang Y, Cui L, ChenWD, Shen SH, Ding LD. The prognostic role of rassf1a promoter methylation in breast cancer: a meta-analysis of published data. PLoS One. 2012;7:e36780.
38. Dong SM, Sun DI, Benoit NE, Kuzmin I, Lerman MI, Sidransky D. Epigenetic inactivation of rassf1a in head and neck cancer. Clin Cancer Res. 2003;9:3635-40. (Pubitemid 37169228)